
Anti-β-Gal-hIgA2
-
Cat.code:
bgal-mab7
- Documents
ABOUT
Recombinant monoclonal human IgA2 antibody against E. coli β-galactosidase
InvivoGen offers an isotype control for InvivoGen’s IgA2 monoclonal antibody (mAb) collection. Anti-β-Gal-IgA2 is a human IgA2 mAb targeting E. coli β-galactosidase (β-Gal).
It features the constant region of the human IgA2 isotype and the variable region of Mouse IgG2a Control (clone: T9C6) targeting E. coli β-Gal. Therefore, it cannot react with human targets.
It was generated by recombinant technology, produced in Chinese hamster ovary (CHO) cells, and purified by affinity chromatography.
All products are for internal research use only, and not for human or veterinary use.
SPECIFICATIONS
Specifications
Flow cytometry
0.2 µm filtered solution in TRIS with glycine, saccharose, and stabilizing agents
Flow cytometry
Absence of binding of Anti-β-Gal-hIgA2 to human cell lines has been tested using flow cytometry. The complete sequence of this antibody has been verified. The absence of bacterial contamination, lipoproteins and endotoxins, has been confirmed using HEK-Blue™ TLR2 and HEK-Blue™ TLR4 cells
CONTENTS
Contents
-
Product:Anti-β-Gal-hIgA2
-
Cat code:bgal-mab7
-
Quantity:200 µg
Shipping & Storage
- Shipping method: Room temperature
- -20°C
- Avoid repeated freeze-thaw cycles
Storage:
Caution:
Details
The human IgA2 is found predominantly in secretory lymphoid tissues, where it plays a critical role in mucosal immunity. It is highly resistant to enzymatic degradation by bacterial proteases, due to a short hinge region. IgA2 displays no complement-dependent cytotoxicity (CDC) and low antibody-dependent cell-mediated cytotoxicity (ADCC).
DOCUMENTS
Documents
Technical Data Sheet
Safety Data Sheet
Certificate of analysis
Need a CoA ?